
AU  - Hol, W. G. J.
AU  - Verlinde, C. L. M. J.
C7  - pp. 10-25
TI  - Macromolecular crystallography and medicine
SN  - 9781119362296
UR  - https://doi.org/10.1107/97809553602060000656
DO  - doi:10.1107/97809553602060000656
SP  - 10-25
KW  - bacterial diseases
KW  - blindness
KW  - cancers
KW  - cardiovascular disorders
KW  - diabetes
KW  - drug design
KW  - drug metabolism
KW  - drug resistance
KW  - fungi
KW  - genetic diseases
KW  - helminths
KW  - infectious diseases
KW  - medicine and crystallography
KW  - neurological disorders
KW  - protozoan infections
KW  - structure-based drug design
KW  - vaccines
KW  - viruses
AB  - Abstract Macromolecular crystallography is discussed in terms of its impact on medicine, and selected examples of protein structures of medical relevance are provided. The application of crystallography to the study of genetic diseases is covered, as well as the role of crystallography in the development of novel pharmaceuticals.
ER  - 

TY  - JOUR
TI  - POSTER PRESENTATION ABSTRACTS
JO  - HPB
VL  - 13
IS  - s3
SN  - 9781119362296
UR  - https://doi.org/10.1111/j.1477-2574.2011.00386.x
DO  - doi:10.1111/j.1477-2574.2011.00386.x
SP  - 174
EP  - 244
PY  - 2011
ER  - 

TY  - JOUR
TI  - 2018 Peripheral Nerve Society Annual Meeting 21-25 July, 2018 Baltimore, Maryland
JO  - Journal of the Peripheral Nervous System
JA  - J Peripher Nerv Syst
VL  - 23
IS  - 4
SN  - 9781119362296
UR  - https://doi.org/10.1111/jns.12290
DO  - doi:10.1111/jns.12290
SP  - 249
EP  - 405
PY  - 2018
ER  - 

C7  - pp. 525-548
TI  - Index
SN  - 9781405169165
UR  - https://doi.org/10.1002/9781444323030.index
DO  - doi:10.1002/9781444323030.index
SP  - 525-548
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 10
IS  - s3
SN  - 9781405169165
UR  - https://doi.org/10.1111/j.1469-0691.2004.0902e.x
DO  - doi:10.1111/j.1469-0691.2004.0902e.x
SP  - 366
EP  - 485
PY  - 2004
ER  - 

TY  - JOUR
TI  - SUBJECT INDEX
JO  - Annals of the New York Academy of Sciences
VL  - 449
IS  - 1
SN  - 9781405169165
UR  - https://doi.org/10.1111/j.1749-6632.1985.tb49542.x
DO  - doi:10.1111/j.1749-6632.1985.tb49542.x
SP  - 101
EP  - 228
PY  - 1985
ER  - 

AU  - Woo, Lynn L.
AU  - Ross, Jonathan H.
C7  - pp. 341-352
TI  - Testicular tumors
SN  - 9781118473313
UR  - https://doi.org/10.1002/9781118473382.ch35
DO  - doi:10.1002/9781118473382.ch35
SP  - 341-352
KW  - Testis tumor
KW  - RPLND
KW  - neoplasm
KW  - orchiectomy
KW  - AFP
KW  - post-chemotherapy
PY  - 1985
AB  - Summary Testicular tumors are rare in the pediatric population. Prepubertal testis tumors differ from postpubertal tumors with respect to histopathology and malignant potential, and management therefore differs. The spectrum of testicular tumors occurring in postpubertal boys is similar to that found in adult men; 90% are malignant and are generally managed by radical orchiectomy with or without platinum-based chemotherapy and/or retroperitoneal lymph node dissection. Yolk sac tumor is the most common malignant testis tumor in prepubertal boys and is typically associated with elevated serum Î±-fetoprotein levels. Teratoma and other stromal tumors, which are almost always benign, account for a majority of prepubertal tumors. The higher likelihood of encountering benign tumors in prepubertal patients makes consideration of testis-sparing surgery important. In postpubertal patients, retroperitoneal lymph node dissection may be required for metastatic disease, and meticulous surgical technique is important to minimize potential complications including bleeding, ejaculatory dysfunction, chylous ascites, and bowel obstruction.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 84
IS  - S2
SN  - 9781118473313
UR  - https://doi.org/10.1002/bjs.1800841402
DO  - doi:10.1002/bjs.1800841402
SP  - 1
EP  - 168
PY  - 1997
ER  - 

TY  - JOUR
AU  - Smith, C. H.
TI  - New approaches to topical therapy
JO  - Clinical and Experimental Dermatology
VL  - 25
IS  - 7
SN  - 9781118473313
UR  - https://doi.org/10.1046/j.1365-2230.2000.00706.x
DO  - doi:10.1046/j.1365-2230.2000.00706.x
SP  - 567
EP  - 574
PY  - 2000
AB  - Despite the rapid and proven efficacy of topical corticosteroids, side-effects can limit their clinical usefulness. Topically active macrolide immunosuppressants such as ascomycin and tacrolimus appear to provide comparable therapeutic potency without significant local or adverse effects. Data from ongoing studies will be crucial in determining the safety of these agents in the long term, and also their place within the current therapeutic armamentarium available for patients with atopic dermatitis. Enzyme inhibitors of PLA2 and PDE?4 currently in the very early stages of clinical development also show potential promise as additional alternative strategies to topical treatment and may perhaps act as steroid sparing agents. Having been in the therapeutic doldrums for years, topical management of atopic dermatitis is likely to show great changes in the very near future.
ER  - 

AU  - Cheetham, Peter S. J.
C7  - pp. 127-177
TI  - Natural Sources of Flavours
SN  - 9781405185431
UR  - https://doi.org/10.1002/9781444317770.ch5
DO  - doi:10.1002/9781444317770.ch5
SP  - 127-177
KW  - natural sources of flavours
KW  - benefits of flavour - premium positioning, cost reductions
KW  - chemical nature of given flavour molecule - determining its properties
KW  - flavour perception
KW  - flavour - combination of sensory inputs
KW  - tastants and umami flavour (to MSG) - recognised as fifth taste sensation
KW  - adenosine monophosphate (AMP)
KW  - guanosine monophosphate (GMP)
KW  - guanosine triphosphate (GTP)
KW  - consumption indices
PY  - 2000
AB  - Summary This chapter contains sections titled: Introduction Properties of flavour molecules Dairy flavours Fermented products Cereal products Vegetable sources of flavour Fruit Other flavour characteristics Fragrance uses Conclusion References
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 142
IS  - S2
SN  - 9781405185431
UR  - https://doi.org/10.1111/jnc.13925
DO  - doi:10.1111/jnc.13925
SP  - 188
EP  - 225
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts and Index of Authors
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 34
IS  - 10
SN  - 9781405185431
UR  - https://doi.org/10.1002/phar.1497
DO  - doi:10.1002/phar.1497
SP  - e180
EP  - e332
PY  - 2014
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 10th Annual ACVIM Forum
JO  - Journal of Veterinary Internal Medicine
VL  - 6
IS  - 2
SN  - 9781405185431
UR  - https://doi.org/10.1111/j.1939-1676.1992.tb03160.x
DO  - doi:10.1111/j.1939-1676.1992.tb03160.x
SP  - 104
EP  - 144
PY  - 1992
ER  - 

AU  - McGurk, Paula
AU  - Elia, Marinos
AU  - Zazzo, Jean-Fabien
C7  - pp. 208-229
TI  - Nutrition and the Pancreas
SN  - 9781405168106
UR  - https://doi.org/10.1002/9781119211945.ch13
DO  - doi:10.1002/9781119211945.ch13
SP  - 208-229
KW  - diabetes mellitus
KW  - diet
KW  - insulin
KW  - intravenous feeding
KW  - nasogastric feeding
KW  - nutrition
KW  - pancreas
PY  - 1992
AB  - Summary The management of diabetes is underpinned by observations that good metabolic control can not only prevent short-term problems, such as those associated with hypo- and hyperglycaemia, but also long-term complications. Special nutritional problems, including those involving nasogastric and intravenous feeding, are discussed in this chapter. There are three main groups of oral drugs that are commonly used in the treatment of type 2 diabetes: biguanides, sulphonylureas, and thiazolidinediones. An insulin pump attempts to imitate the healthy pancreas, although it delivers insulin into the peripheral circulation, whereas the pancreas delivers it into the portal circulation, which produces important 'first-pass' metabolic effects in the liver. In summary, while the healthy diet for healthy people is also generally appropriate for people with diabetes, there are also specific considerations associated with the timing of food ingestion.
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol
VL  - 53
IS  - S2
SN  - 9781405168106
UR  - https://doi.org/10.1002/ppul.24152
DO  - doi:10.1002/ppul.24152
SP  - S148
EP  - S456
PY  - 2018
ER  - 

AU  - Gwaltney-Brant, Sharon M.
C7  - pp. 185-206
TI  - Poisoning
SN  - 9780470961629
UR  - https://doi.org/10.1002/9781118704738.ch10
DO  - doi:10.1002/9781118704738.ch10
SP  - 185-206
KW  - Acetaminophen, ibuprofen and amphetamine
KW  - Anticoagulant rodenticides and bromethalin
KW  - Carbamate insecticides and paraquat
KW  - Cholecalciferol rodenticides, strychnine and zinc phosphide
KW  - Ethylene glycol (EG)
KW  - Marijuana, cocaine and alcohols
KW  - Organophosphates (OPs)
KW  - Phencyclidine (PCP) and caffeine
KW  - Poisoning and toxicology testing
KW  - Sodium monofluoroacetate and metaldehyde
PY  - 2018
AB  - Summary This chapter contains sections titled: Overview of Intentional Poisonings Evidence and History Diagnostics Agents Used in Animal Poisonings Summary References
ER  - 

TY  - JOUR
TI  - Invited Speakers
JO  - Mycoses
VL  - 55
IS  - s4
SN  - 9780470961629
UR  - https://doi.org/10.1111/j.1439-0507.2012.02204.x
DO  - doi:10.1111/j.1439-0507.2012.02204.x
SP  - 1
EP  - 56
PY  - 2012
ER  - 

TY  - JOUR
TI  - ACR Meeting
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 64
IS  - S10
SN  - 9780470961629
UR  - https://doi.org/10.1002/art.37735
DO  - doi:10.1002/art.37735
SP  - S1
EP  - S1216
PY  - 2012
AB  - Abstract http://acrmeeting.wiley.com/
ER  - 

TY  - JOUR
TI  - Poster sessions
JO  - Obesity Reviews
VL  - 6
IS  - s1
SN  - 9780470961629
UR  - https://doi.org/10.1111/j.1467-789X.2005.00206.x
DO  - doi:10.1111/j.1467-789X.2005.00206.x
SP  - 46
EP  - 196
PY  - 2005
ER  - 

AU  - Murray, Patrick R.
AU  - Holmes, Barry
AU  - Aucken, Hazel M.
TI  - Citrobacter, Enterobacter, Klebsiella, Plesiomonas, Serratia, and Other Members of the Enterobacteriaceae
SN  - 9780470686386
UR  - https://doi.org/10.1002/9780470688618.taw0057
DO  - doi:10.1002/9780470688618.taw0057
KW  - Enterobacteriaceae-important members, Escherichia, Shigella, Salmonella, Proteus
KW  - Citrobacter species-motile organisms fermenting glucose with gas production
KW  - Citrobacter-resembling other members of Enterobacteriaceae
KW  - Klebsiella organisms-nonmotile and capsulate
KW  - Klebsiella species and chief biochemical reactions
KW  - susceptibility to antimicrobial agents
KW  - strains of K. pneumoniae-giving rise to community-acquired cases of severe bronchopneumonia
KW  - Cedecea-motile, producing gas from glucose
PY  - 2005
AB  - Abstract
ER  - 
